The Renal Standing Committee oversees the consensus based entity's portfolio of renal measures, which includes measures for hemodialysis, standardized mortality and transfusion ratios, phosphorus concentration, hypercalcemia, pediatric hemodialysis, Angiotensin Converting Enzyme  Inhibitor or Angiotensin Receptor Blocker therapy, optimal end stage renal disease starts, and bloodstream infections in hemodialysis patients.